Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03723603 · ClinicalTrials.gov registry record · NA
An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds
A NA study, sponsored by Medline Industries.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03723603: Clinical Trial NA study, sponsored by Medline Industries.
NCT03723603 is a NA study that was terminated before completion, run by Medline Industries. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03723603, a NA study, was terminated before completion, sponsored by Medline Industries.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Patients who meet the inclusion criteria will be provided with fibrillar collagen powder dressing. The powder dressing will be used in accordance with its label. After cleansing the wound by the clinical site staff, the powder is placed directly on the wound, and then the wound will be covered with an appropriate moisture retentive secondary dressing. Patients will visit the clinic twice a week to have the powder re-applied. Wound evaluations will take place once a week at the outpatient clinic, with the intervention lasting up to twelve weeks. Concurrent standard of care, such as compression for venous ulcers, will be provided.
Interventions
- DEVICE Fibrillar collagen powder dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-11-09 |
| Est. Completion | 2019-07-30 |
| Phase | NA |
Why NCT03723603 stopped before completion
NCT03723603 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Fibrillar collagen powder dressing is the first listed.
NCT03723603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03723603 about?
NCT03723603 is a clinical study titled "An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds". Patients who meet the inclusion criteria will be provided with fibrillar collagen powder dressing. The powder dressing will be used in accordance with its label. After cleansing the wound by the clinical site staff, the powder is placed directly on the wound, and then the wound will be covered with ...
What is the current status of trial NCT03723603?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2018-11-09. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT03723603?
The interventions under investigation include: Fibrillar collagen powder dressing (DEVICE).
Who is sponsoring clinical trial NCT03723603?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03723603's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI